Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 Receptor Agonists After Heart Transplantation.

MLA

Donald, Elena M., et al. “Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 Receptor Agonists After Heart Transplantation.” Clinical Transplantation, vol. 38, no. 7, July 2024, p. e15401. EBSCOhost, https://doi.org/10.1111/ctr.15401.

APA

Donald, E. M., Driggin, E., Choe, J., Batra, J., Vargas, F., Lindekens, J., Fried, J. A., Raikhelkar, J. K., Bae, D. J., Oh, K. T., Yuzefpolskaya, M., Colombo, P. C., Latif, F., Sayer, G., Uriel, N., Clerkin, K. J., & DeFilippis, E. M. (2024). Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 Receptor Agonists After Heart Transplantation. Clinical Transplantation, 38(7), e15401. https://doi.org/10.1111/ctr.15401

Chicago

Donald, Elena M, Elissa Driggin, Jason Choe, Jaya Batra, Fabian Vargas, Jordan Lindekens, Justin A Fried, et al. 2024. “Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 Receptor Agonists After Heart Transplantation.” Clinical Transplantation 38 (7): e15401. doi:10.1111/ctr.15401.